Bevacizumab (Avastin®) for the management of anterior chamber neovascularization and neovascular glaucoma
Dimitrios Brouzas, Antonios Charakidas, Marilita Moschos, Chryssanthi Koutsandrea, Michael Apostolopoulos, Stefanos Baltatzis1st Department of Ophthalmology, University of Athens, Athens, GreecePurpose: To establish the efficacy and safety of intravitreal bevacizumab in reducing iris and anterior ch...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2009-11-01
|
| Series: | Clinical Ophthalmology |
| Online Access: | http://www.dovepress.com/bevacizumab-avastinreg-for-the-management-of-anterior-chamber-neovascu-a3767 |